Gwendolyn Binder - Jan 18, 2023 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
President, Science & Technology
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jan 18, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 07:50 PM
Previous filing
Oct 18, 2022
Next filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +176K $0.00 176K Jan 18, 2023 Common Stock 176K $11.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.

Remarks:

President, Science & Technology